A study to compare two chemotherapy regimens like cisplatin&etoposide vs paclitaxel&carboplatin with concurrent RT in non small cell lung cancers
- Conditions
- Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung
- Registration Number
- CTRI/2021/09/036500
- Lead Sponsor
- svims tirupati
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 34
Histopathologically proven non small cell lung cancer patients.
2.Unresectable lung cancers according to NCCN /BTS guidelines VI
3.Patients with adequate hematologic parameters hemoglobin HB >=10g/dl, total white blood cell (WBC) >= 4000/mm3 and platelets >= 100,000/mm3 )and renal function >= 60ml/min.
4. Patients with Eastern Cooperative Oncology Group (ECOG) performance status (0-2)
5.Patients having age 18-65 years.
6.Patients who are willing to give an approved informed consent
Patients who already treated with surgery ,radiation therapy or chemotherapy for ca lung.
Patients with known distant metastases & malignant pleural effusion.
Patients with (ECOG) performance status 3- 4
Clinically significant cardiovascular comorbidities.
5.Pregnant women and lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method